No attachments available.
Miscellaneous / Reagents - Custom Conjugates Legacy, Brilliant and Early Access Dyes
Contact and place of performance
Tonia L Alexander
BETHESDA, MD 20892
USA
The National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center (VRC) intends to negotiate on an other than full and open competition basis with Becton, Dickinson and Company, 2350 Qume Drive, San Jose, CA 95131 to procure a very large number of unique and distinct reagents, fluorescently conjugated monoclonal antibodies based on custom conjugates Legacy, Brilliant and Early Access Dyes tha...
View moreThe National Institute of Allergy and Infectious Diseases Vaccine Research Center (VRC) intends to negotiate a sole source contract with Becton, Dickinson and Company for the procurement of custom conjugate reagents, including Legacy, Brilliant, and Early Access Dyes. These fluorescently conjugated monoclonal antibodies are utilized in flow cytometry to analyze immune responses for preclinical vaccine development and basic research. The acquisition covers a high volume of unique reagents in sizes ranging from 50ug to 3mg, which are necessary to identify and enumerate blood cell types during immunoassays.
This requirement is classified under NAICS code 325413 In-Vitro Diagnostic Substance Manufacturing and PSC code 99. The government intends to award a single firm-fixed-price Indefinite Delivery, Indefinite Quantity contract featuring a base year and two one-year option periods. Performance and delivery will occur in Bethesda, Maryland, with orders fulfilled approximately five to seven days after receipt. Becton, Dickinson and Company is the sole manufacturer and patent holder for these proprietary reagents, which are required on a continuous basis to maintain experimental consistency and prevent external variables from influencing research results.
The statutory authority for this non-competitive acquisition is 41 U.S.C. 253 (c)(1), as implemented by FAR 6.302-1 for only one source. Under solicitation number NIHAO2017060, capabilities statements from responsible sources must be submitted via email to Tonia L. Alexander by 5:00 pm Eastern Standard Time on November 21, 2016. All detailed information provided by the closing date will be reviewed to determine if the requirement should be competed, though the final decision remains within the discretion of the government.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.